Ketamine, SSRIs & the Future of Psychedelic Therapy - Dr. Remi Drozd episode artwork

EPISODE · Aug 17, 2026 · 53 MIN

Ketamine, SSRIs & the Future of Psychedelic Therapy - Dr. Remi Drozd

from The Psychedelic Podcast · host Third Wave

In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Dr. Remi Drozd back to explore ketamine, SSRIs, and the changing landscape of psychedelic mental health care. Find full show notes and links here: https://thethirdwave.co/podcast/episode-369/?ref=278 Since Remi first appeared on the podcast in Episode 182, Lucid Therapeutics has grown from a small ketamine practice into a ten-room interventional mental health clinic offering ketamine treatments, Spravato, TMS, therapy, integration support, and other approaches. Paul and Remi examine one of the less-discussed challenges facing psychedelic medicine: many prospective patients are already taking antidepressants and other psychiatric medications. Remi explains why SSRI tapering needs to be individualized, how ketamine may support some patients through treatment transitions, and what clinicians may need to consider as psilocybin and other psychedelic therapies move closer to mainstream clinical use. Dr. Remi Drozd is a board-certified physician and founder of Lucid Therapeutics in Santa Barbara. After 15 years practicing emergency medicine, he shifted toward more integrative approaches to mental health care. He has trained in ketamine therapy and MDMA-assisted therapy through MAPS. His work focuses on individualized care, expanding access, and preparing for how emerging psychedelic treatments may fit into the existing mental healthcare system. Highlights: The growth of Lucid Therapeutics Expanding access through insurance-based care Navigating ketamine alongside SSRIs Why SSRI tapering must be individualized Withdrawal versus the return of depression Preparing patients for future psilocybin therapy The infrastructure required for psychedelic treatment Bringing longer psychedelic sessions into existing clinics Episode Links: SSRI Deprescribing & Psychedelic Readiness Training: https://edu.psychedeliccoaching.institute/ssri-deprescribing-and-psychedelic-readiness-certification/?ref=8 Lucid Therapeutics: https://www.thelucid.life/ Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.

Episode metadata supplied by the publisher feed · Published Aug 17, 2026

Embed this episode

Ready to play

Ketamine, SSRIs & the Future of Psychedelic Therapy - Dr. Remi Drozd

0:00 53:38

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Psychedelic Podcast?

This episode is 53 minutes long.

When was this The Psychedelic Podcast episode published?

This episode was published on August 17, 2026.

Can I download this The Psychedelic Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!